Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
4 clinical trials · Condition
◉ Watch Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
| Record | Firm | Date |
|---|---|---|
| Prevalence and Characteristics of Transthyretin Amyloidosis in Patients With Left Ventricular Hypertrophy of Unknown Etiology (NCT03842163) | Pfizer | 2018-07-09 |
Track Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) automatically
Every clearance here is in the API, with alerts when new ones post.